» Articles » PMID: 31231383

Attenuation of Human Respiratory Viruses by Synonymous Genome Recoding

Overview
Journal Front Immunol
Date 2019 Jun 25
PMID 31231383
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Using computer algorithms and commercial DNA synthesis, one or more ORFs of a microbial pathogen such as a virus can be recoded and deoptimized by several strategies that may involve the introduction of up to thousands of nucleotide (nt) changes without affecting amino acid (aa) coding. The synonymous recoding strategies that have been applied to RNA viruses include: deoptimization of codon or codon-pair usage, which may reduce protein expression among other effects; increased content of immunomodulatory CpG and UpA RNA, which increase immune responses and thereby restrict viral replication; and substitution of serine and leucine codons with synonymous codons for which single-nt substitutions can yield nonsense codons, thus limiting evolutionary potential. This can reduce pathogen fitness and create potential live-attenuated vaccines that may have improved properties. The combined approach of genome recoding, synthetic biology, and reverse genetics offers several advantages for the generation of attenuated RNA viruses. First, synonymous recoding involves many mutations, which should reduce the rate and magnitude of de-attenuation. Second, increasing the amount of recoding can provide increased attenuation. Third, because there are no changes at the aa level, all of the relevant epitopes should be expressed. Fourth, attenuation frequently does not compromise immunogenicity, suggesting that the recoded viruses have increased immunogenicity per infectious particle. Synonymous deoptimization approaches have been applied to two important human viral pathogens, namely respiratory syncytial virus (RSV) and influenza A virus (IAV). This manuscript will briefly review the use of these different methods of synonymous recoding to generate attenuated RSV and IAV strains. It also will review the characterization of these vaccine candidates and in animal models, and describe several surprising findings with respect to phenotypic and genetic instability of some of these candidates.

Citing Articles

Elegant and Innovative Recoding Strategies for Advancing Vaccine Development.

Meurens F, Renois F, Karniychuk U Vaccines (Basel). 2025; 13(1).

PMID: 39852857 PMC: 11768987. DOI: 10.3390/vaccines13010078.


Interferon-Stimulated Genes that Target Retrovirus Translation.

Jager N, Pohlmann S, Rodnina M, Ayyub S Viruses. 2024; 16(6).

PMID: 38932225 PMC: 11209297. DOI: 10.3390/v16060933.


Human parainfluenza virus 3 vaccine candidates attenuated by codon-pair deoptimization are immunogenic and protective in hamsters.

Afroz S, Saul S, Dai J, Surman S, Liu X, Park H Proc Natl Acad Sci U S A. 2024; 121(25):e2316376121.

PMID: 38861603 PMC: 11194498. DOI: 10.1073/pnas.2316376121.


Developing Next-Generation Live Attenuated Vaccines for Porcine Epidemic Diarrhea Using Reverse Genetic Techniques.

Yu R, Dong S, Chen B, Si F, Li C Vaccines (Basel). 2024; 12(5).

PMID: 38793808 PMC: 11125984. DOI: 10.3390/vaccines12050557.


Intranasal respiratory syncytial virus vaccine attenuated by codon-pair deoptimization of seven open reading frames is genetically stable and elicits mucosal and systemic immunity and protection against challenge virus replication in hamsters.

Levy M, Chen J, Kaiser J, Park H, Liu X, Yang L PLoS Pathog. 2024; 20(5):e1012198.

PMID: 38739647 PMC: 11115275. DOI: 10.1371/journal.ppat.1012198.


References
1.
Krieg A . CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol. 2002; 20:709-60. DOI: 10.1146/annurev.immunol.20.100301.064842. View

2.
Cello J, Paul A, Wimmer E . Chemical synthesis of poliovirus cDNA: generation of infectious virus in the absence of natural template. Science. 2002; 297(5583):1016-8. DOI: 10.1126/science.1072266. View

3.
Kozak M . Pushing the limits of the scanning mechanism for initiation of translation. Gene. 2002; 299(1-2):1-34. PMC: 7126118. DOI: 10.1016/s0378-1119(02)01056-9. View

4.
Jenkins G, Holmes E . The extent of codon usage bias in human RNA viruses and its evolutionary origin. Virus Res. 2003; 92(1):1-7. DOI: 10.1016/s0168-1702(02)00309-x. View

5.
Gustafsson C, Govindarajan S, Minshull J . Codon bias and heterologous protein expression. Trends Biotechnol. 2004; 22(7):346-53. DOI: 10.1016/j.tibtech.2004.04.006. View